Epoprostenol for very low birth weight (VLBW) infants: a novel dilution protocol

Submitted: 17 November 2014
Accepted: 17 November 2014
Published: 31 October 2013
Abstract Views: 1084
PDF: 1138
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Epoprostenol has been the first effective treatment for severe pulmonary arterial hypertension. Epoprostenol is provided in vials for adult therapy. To our knowledge there are no reports on specific dilution protocols for epoprostenol in VLBW infants, when very small infusion rates are required. We describe the dilution protocol we applied to a preterm infant who was born at 30 weeks of gestational age with a weight of 1.000 g. Our dilution protocol keeps the recommended dilution ratios, and the required solution pH, for very small dosages of epoprostenol, using the same diluent vial. Our method allows a correct and safe administration of epoprostenol in VLBW infants.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Rugolotto, S., Beghini, R., Cogo, I., Sidoti, G., Padovani, E., & Pietrobelli, A. (2013). Epoprostenol for very low birth weight (VLBW) infants: a novel dilution protocol. La Pediatria Medica E Chirurgica, 35(5). https://doi.org/10.4081/pmc.2013.31

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.